Shruthi Karnam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shruthi Karnam has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Amogh Changavi
Vision Science Graduate Group, University of California Berkeley, Berkeley, CA, United States; Herbert Wertheim School of Optometry & Vision Science, University of California Berkeley, Berkeley, CA, United States
1 shared publication - Anja Osterwald
Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
1 shared publication - Christoph Ullmer
Roche Pharma Research & Early Development Roche Innovation Center Basel, F. Hoffmann‐La Roche Ltd Basel Switzerland
1 shared publication - Emily Lauren Ward
Vision Science Graduate Group, University of California Berkeley, Berkeley, CA, United States; Herbert Wertheim School of Optometry & Vision Science, University of California Berkeley, Berkeley, CA, United States
1 shared publication - Iris Navarro
Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA
1 shared publication - Jeremy M. Sivak
Donald K Johnson Eye Institute, University Health Network, Toronto, ON, Canada; Department of Ophthalmology and Vision Science, University of Toronto, Temerty Faculty of Medicine, Canada
1 shared publication
Latest Publications
- Open Access
- 18 March 2026
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 112, 101460
The role of prostanoids in the retina and optic nerve in health and disease
- 18 March 2026
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 112, 101460
Open AccessThe role of prostanoids in the retina and optic nerve in health and disease
- Open Access
- 29 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 744
Elevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients
Dysregulated levels of growth/differentiation factor-15 (GDF15), a divergent member of the transforming growth factor-beta super family, have been found to be associated with the pathology of various diseases. In this study, we evaluated the levels of GDF15 in aqueous humor (AH) and serum samples derived from primary open-angle glaucoma (POAG) and age- and gender-matched non-glaucoma (cataract) patients to assess the plausible association between GDF15 and POAG. GDF15 levels were determined using an enzyme-linked immunosorbent assay, and data analysis was performed using the Wilcoxon rank sum test, or the Kruskal–Wallis test and linear regression. GDF15 levels in the AH (n = 105) of POAG patients were significantly elevated (by 7.4-fold) compared to cataract patients (n = 117). Serum samples obtained from a subgroup of POAG patients (n = 41) also showed a significant increase in GDF15 levels (by 50%) compared to cataract patients. GDF15 levels were elevated in male, female, African American, and Caucasian POAG patients. This study reveals a significant and marked elevation of GDF15 levels in the AH of POAG patients compared to non-glaucoma cataract control patients. Although serum GDF15 levels were also elevated in POAG patients, the magnitude of difference was much smaller relative to that found in the AH.
- 29 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 744
Open AccessElevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients
Dysregulated levels of growth/differentiation factor-15 (GDF15), a divergent member of the transforming growth factor-beta super family, have been found to be associated with the pathology of various diseases. In this study, we evaluated the levels of GDF15 in aqueous humor (AH) and serum samples derived from primary open-angle glaucoma (POAG) and age- and gender-matched non-glaucoma (cataract) patients to assess the plausible association between GDF15 and POAG. GDF15 levels were determined using an enzyme-linked immunosorbent assay, and data analysis was performed using the Wilcoxon rank sum test, or the Kruskal–Wallis test and linear regression. GDF15 levels in the AH (n = 105) of POAG patients were significantly elevated (by 7.4-fold) compared to cataract patients (n = 117). Serum samples obtained from a subgroup of POAG patients (n = 41) also showed a significant increase in GDF15 levels (by 50%) compared to cataract patients. GDF15 levels were elevated in male, female, African American, and Caucasian POAG patients. This study reveals a significant and marked elevation of GDF15 levels in the AH of POAG patients compared to non-glaucoma cataract control patients. Although serum GDF15 levels were also elevated in POAG patients, the magnitude of difference was much smaller relative to that found in the AH.